Selon une méta-analyse récente, 31% des personnes qui cessent un antidépresseur éprouvent au moins un symptôme de sevrage. Moins d’un sur 33 éprouve des symptômes graves. ⚠️Les antidépresseurs dont le retrait cause le + de sevrage ? L’imipramine, la desvenlafaxine, la

A recent commentary by Michelle S. Keller, PhD & Utibe R. Essien, MD MPH addresses inequities in #deprescribing research among older adults, by introducing a framework to improve #deprescribing equity. The framework outlines key strategies to adapt research to specific communities, including

Le Réseau et la déprescription dans un nouvel article de L’actualité! Vous y trouverez une définition de la polypharmacie et de ses risques, ainsi que trois conseils pratiques pour assurer un usage sécuritaire de ses médicaments ou de ceux d’un(e) proche. Un excellent

Important findings from a Tramadol #deprescribing case study in long-term care settings:

FREE WEBINAR: Exploring the potential value of N-of-1 trials & the suitability of this methodology in #deprescribing research. What is an N-of-1 trial? Multiple crossover trials, usually randomized and often blinded, conducted in a single patient. Learn more about this method &

Need a refresher on drug interactions? In this AchieveCE webinar, pharmacist & WVU Pharmacy professor Mark Garofoli gives a deep dive into polypharmacy, drug interactions to avoid in older adults, and how #deprescribing can prevent harmful side effects: youtube.com/watch?v=B6FsBj…

Update to a 2016 systematic review & meta-analysis: the impact of #deprescribing on mortality and health outcomes in older adults 153 new studies were added to the analysis (259 studies total), which found that: - Deprescribing interventions did not significantly reduce

CADeN's executive committee is regrouping in Ottawa (& virtually!) today to look back on the past year’s accomplishments, and strategize for future opportunities in public awareness, health care provider education, Indigenization of the network, research... and much more! The

FREE WEBINAR: Sept 10th, 12-1PM EST Don’t miss GeriMedRisk’s next educational rounds webinar to review the current & emerging evidence on insomnia treatments for older adults! A case study will be presented to apply knowledge from this session. gerimedrisk.com/Rounds.htm

From disruption to opportunity: CADeN members Emily McDonald, Cheryl Sadowski & Leslie Gaudette will be sharing novel research and approaches to health promotion at the CDA-AMC Symposium. #CDA_AMC With this year’s theme of embracing change in healthcare, we hope to inspire

Congratulations to Dr. Jim Silvius for this recognition! We are lucky to have learned from his leadership as CADeN's co-founder & executive director from 2016 to 2024, and look forward to his continued accomplishments at the CDA-AMC. #CDA_AMC

Minister Mark Holland delivered welcoming remarks at the #CDA_AMC Symposium this morning, highlighting the significant burden of inappropriate medication use on Canadians and underscoring the need for a national strategy in this area, led by CDA-AMC.

CADeN director Emily McDonald shared findings of an updated analysis of the cost of potentially inappropriate medications in Canada in 2021, and how they’ve changed since 2013. Curious? The publication is coming very soon 👀 CDA-AMC #CDA_AMC

Morning panel: How can we improve patient safety and outcomes? Members of the CDA-AMC Appropriate Use Committee shared their perspectives & vision for a pan-Canadian, coordinated approach to reach these goals. Experts included Connie Newman, Chair of CADeN’s public awareness

As Stephen Samis put it so eloquently: it’s not often that a committee puts forth a strategy and at the same time the legislation passes mandating that strategy. Appropriate use for 🇨🇦 is a mandate of CDA-AMC CADeN is here to help lead the way

Kicking off CDA-AMC Diverse Perspectives session, CADeN public awareness committee member Leslie Gaudette presented: - the essential role of public engagement in the design & implementation of med. appropriateness initiatives - the value of partnerships in these efforts, as

Leslie Gaudette, Council of Senior Citizens' Organizations of BC, just finished her presentation on "Prioritizing Community Partnerships: A Collaborative Approach to Promoting Medication Appropriateness Across Diverse British Columbia Communities" at Symposium 2024. #CDA_AMC

CADeN advocates for the safe use of medications, for all. Cheryl Sadowski presented the methodology, findings, and lessons learned from CADeN's first steps towards Indigenization and decolonization of health promotion and research activities, through relationship building,